Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Go back to Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 18.11 -0.08 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.19 | 52 Week High | $0.19 | |||
| Open | $18.51 | 52 Week Low | $0.07 | |||
| Day High | $18.58 | P/E | N/A | |||
| Day Low | $17.95 | EPS | $-0.01 | |||
| Volume | 1,469,867 | |||||
